Physician
Anesthesiology
Dr. Jaspreet S. Brar, MD
|
|
Give Review
Dr. Jaspreet S. Brar works in the field of Anesthesiology. He went to medical school at Texas Tech University Health Sciences Center School of Medicine. Dr. Jaspreet S. Brar has written publications. He has 64 publications published with PubMed. The lastest publication is: 'Mini-Mental State Examination (MMSE) performance of partially remitted community-dwelling patients with schizophrenia.' He is registered with Medicare and accepts Medicare payments.
Publications
- Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study.
- Randomized placebo-controlled adjunctive study of an extract of withania somnifera for cognitive dysfunction in bipolar disorder.
- Physical activity and depressive symptoms in older adults.
- Changes in weight and other metabolic indicators in persons with schizophrenia following a switch to aripiprazole.
- The impact of olanzapine on tardive dyskinetic symptoms in a state hospital population.
- Cardiovascular disease and metabolic risk factors in male patients with schizophrenia, schizoaffective disorder, and bipolar disorder.
- Dietary intake of patients with schizophrenia.
- Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder.
- Nutritional assessment of patients with schizophrenia: a preliminary study.
- Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart review.
- Antinuclear and gastric parietal cell autoantibodies in schizophrenic patients.
- Non-right sidedness: an association with lower IL-2 production.
- Differences in serum interleukin-6 (IL-6) between healthy dextral and non-dextral subjects.
- Feasibility of pedometers for adults with schizophrenia: pilot study.
- Co-occurrence of schizophrenia and Treacher Collins syndrome.
- Autoimmunity in schizophrenia: a review of recent findings.
- Association study of schizophrenia and the IL-2 receptor beta chain gene.
- Immune abnormalities in schizophrenia: evidence for the autoimmune hypothesis.
- Obesity and medical illnesses in psychiatric patients admitted to a long-term psychiatric facility.
- Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness.
- Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients. The influence of age at onset and negative symptoms.
- Impaired mitogen (PHA) responsiveness and increased autoantibodies in Caucasian schizophrenic patients with the HLA B8/DR3 phenotype.
- Altered interleukin-2 production in schizophrenia: association between clinical state and autoantibody production.
- Association study of schizophrenia and the dopamine D3 receptor gene locus in two independent samples.
- 5-HT2 receptor gene locus: association with schizophrenia or treatment response not detected.
- Functional hypofrontality and working memory dysfunction in schizophrenia.
- The prevalence of autoantibodies among right and left handed schizophrenic patients and control subjects.
- Lack of association of schizophrenia with the neurotrophin-3 gene locus.
- Electroencephalographic sleep and cerebral morphology in functional psychoses: a preliminary study with computed tomography.
- Frequency of sexual dysfunctions in patients with schizophrenia on haloperidol, clozapine or risperidone.
- Left-handed first-episode, neuroleptic-naive schizophrenic patients have a higher prevalence of autoantibodies.
- Generalizability of first-episode studies in schizophrenia.
- An association between anti-hippocampal antibody concentration and lymphocyte production of IL-2 in patients with schizophrenia.
- Impact of risperidone on seclusion and restraint at a state psychiatric hospital.
- The effects of risperidone and olanzapine on the indications for clozapine.
- Elevated IgG anti-histone antibodies in a subgroup of medicated schizophrenic patients.
- Effects of hydrocortisone infusion on rCBF in schizophrenic patients during a memory task. An O15 PET Study.
- PET brain mapping study of auditory verbal supraspan memory versus visual fixation in schizophrenia.
- Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine.
- Can clinical features of bipolar-I disorder be assessed reliably on the telephone?
- Bupropion sustained release as a smoking cessation treatment in remitted depressed patients maintained on treatment with selective serotonin reuptake inhibitor antidep...
- Mini-Mental State Examination (MMSE) performance of partially remitted community-dwelling patients with schizophrenia.
- Psychotropic drug prescription patterns among patients with bipolar I disorder.
- Risperidone use at a state hospital: a clinical audit 2 years after the first wave of risperidone prescriptions.
- The effects of clozapine on negative symptoms in patients with schizophrenia with minimal positive symptoms.
- Topiramate as add-on treatment for patients with bipolar mania.
- Illness characteristics and their association with prescription patterns for bipolar I disorder.
- Weight gain over 4 months in schizophrenia patients: a comparison of olanzapine and risperidone.
- Hydrocortisone induced regional cerebral activity changes in schizophrenia: a PET scan study.
- The use of concomitant medications in psychiatric inpatients treated with either olanzapine or other antipsychotic agents: a naturalistic study at a state psychiatric ...
- Leukopenia in clozapine treated patients may be induced by other drugs: a case series.
- The prevalence of the metabolic syndrome in patients with schizoaffective disorder--bipolar subtype.
- Evaluation of familial influences on the course and severity of schizophrenia among US and Indian cases.
- A random-assignment, double-blind, clinical trial of once- vs twice-daily administration of quetiapine fumarate in patients with schizophrenia or schizoaffective disor...
- Self-reported body weight perception and dieting practices in community-dwelling patients with schizophrenia.
- A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type.
- Increased caffeine and nicotine consumption in community-dwelling patients with schizophrenia.
- Assessment of strategies for switching patients from olanzapine to risperidone: a randomized, open-label, rater-blinded study.
- Low cardiorespiratory fitness and physical functional capacity in obese patients with schizophrenia.
- Dose-dependent rapid-onset akathisia with aripiprazole in patients with schizoaffective disorder.
- Attitudes towards taking Medicine among those patients who either received Olanzapine or First Generation Antipsychotic Agents.
- "Does one shoe fit all?".
- Body mass index and quality of life in community-dwelling patients with schizophrenia.
Schools
Texas Technical University
Alton Ochsner Med Fndn
Wake Forest University Baptist Med Center
Doctors Specialties
- Anesthesiology
Accepted Insurances
Education
-
Wake Forest University -
Ochsner Clinic Foundation -
Texas Tech University Health Sciences Center School of Medicine
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1801870704 |
| Last Name Of The Provider | BRAR |
| First Name Of The Provider | JASPREET |
| View All |
Similar Doctors
|
|
Dr. William R. Rinker, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Hammen, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David A. Paly, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katherine W. Holley, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian E. Wallace, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adam D. Demars, MD |
|
|
Dr. Sunanda Pillai, MD
This Doctor is OpenDoctor Recommended.
|